Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Cataract panel. NGS panel of 69 genes. Genologica Medica Spain | 146 | 69 |
|
Non-syndromic hearing loss panel. 95-gene NGS panel. Genologica Medica Spain | 146 | 94 |
|
Nephrotic syndrome panel. 36-gene NGS panel. Genologica Medica Spain | 49 | 36 |
|
Alport syndrome panel. 6-gene NGS panel. Genologica Medica Spain | 9 | 6 |
|
Thrombocytopenia panel. 34-gene NGS panel. Genologica Medica Spain | 53 | 34 |
|
Bleeding disorder / coagulopathy panel. NGS panel of 62 genes. Genologica Medica Spain | 96 | 62 |
|
Alport Syndrome (NGS Panel and Copy Number Analysis) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 5 | 5 |
|
Hearing Loss, Comprehensive Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 142 | 84 |
|
Deafness, autosomal dominant: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 40 | 39 |
|
Comprehensive Glomerular Proteinuria NGS Panel Fulgent Genetics United States | 182 | 76 |
|
Syndromic Hearing Loss NGS Panel Fulgent Genetics United States | 223 | 83 |
|
MYH9-Related Disorder (MYH9 Single Gene Test) Fulgent Genetics United States | 2 | 1 |
|
Comprehensive Hearing Loss NGS Panel Fulgent Genetics United States | 332 | 167 |
|
Nonsyndromic Hearing Loss NGS Panel Fulgent Genetics United States | 146 | 99 |
|
Comprehensive Primary Immunodeficiency NGS Panel Fulgent Genetics United States | 1048 | 472 |
|
Fulgent Genetics United States | 74 | 44 |
|
Comprehensive Thrombosis, Platelet Disorder, and Coagulation Deficiency NGS Panel Fulgent Genetics United States | 146 | 82 |
|
Fulgent Genetics United States | 68 | 41 |
|
DEAFNESS, NONSYNDROMIC SENSORINEURAL (AUTOSOMAL DOMINANT) Laboratorio de Genetica Clinica SL Spain | 10 | 10 |
|
Deafness, autosomal dominant nonsyndromic sensorineural 17 Labor Dr. Wisplinghoff Germany | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.